File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Hormonal control of the metabolic machinery of hepatocellular carcinoma

TitleHormonal control of the metabolic machinery of hepatocellular carcinoma
Authors
Issue Date2016
PublisherAME Publishing Company. The Journal's web site is located at http://www.thehbsn.org/
Citation
Hepatobiliary Surgery and Nutrition, 2016, v. 5 n. 3, p. 195-197 How to Cite?
AbstractHepatocellular carcinoma (HCC) is one of the most fatal malignancies worldwide. It is an aggressive cancer with low cure rate, frequent metastasis, and highly resistant to conventional chemotherapies. Better knowledge regarding the molecular and metabolic alterations in HCC will be instrumental to the development of novel therapeutic interventions against HCC. In the August 2015 issue of Hepatology, Nie et al. reports an important molecular pathway that contributes to the Warburg Effect in HCC. They have beautifully demonstrated that the loss of a component of a hormonal system, the mineralocorticoid receptor (MR), reprogrammed the metabolic machinery of HCC cells to aerobic glycolysis through the miR-338-3p-PKL/R axis. The implication could be that in addition to drugs that directly target the metabolic enzymes in cancer cells, more translational efforts could be focused on the development of drugs that involve the activation of the MR-aldosterone system or other hormonal systems to target the Warburg effect.
Persistent Identifierhttp://hdl.handle.net/10722/232159
ISSN

 

DC FieldValueLanguage
dc.contributor.authorWong, CCL-
dc.contributor.authorWong, CM-
dc.contributor.authorNg, IOL-
dc.date.accessioned2016-09-20T05:28:08Z-
dc.date.available2016-09-20T05:28:08Z-
dc.date.issued2016-
dc.identifier.citationHepatobiliary Surgery and Nutrition, 2016, v. 5 n. 3, p. 195-197-
dc.identifier.issn2304-3881-
dc.identifier.urihttp://hdl.handle.net/10722/232159-
dc.description.abstractHepatocellular carcinoma (HCC) is one of the most fatal malignancies worldwide. It is an aggressive cancer with low cure rate, frequent metastasis, and highly resistant to conventional chemotherapies. Better knowledge regarding the molecular and metabolic alterations in HCC will be instrumental to the development of novel therapeutic interventions against HCC. In the August 2015 issue of Hepatology, Nie et al. reports an important molecular pathway that contributes to the Warburg Effect in HCC. They have beautifully demonstrated that the loss of a component of a hormonal system, the mineralocorticoid receptor (MR), reprogrammed the metabolic machinery of HCC cells to aerobic glycolysis through the miR-338-3p-PKL/R axis. The implication could be that in addition to drugs that directly target the metabolic enzymes in cancer cells, more translational efforts could be focused on the development of drugs that involve the activation of the MR-aldosterone system or other hormonal systems to target the Warburg effect.-
dc.languageeng-
dc.publisherAME Publishing Company. The Journal's web site is located at http://www.thehbsn.org/-
dc.relation.ispartofHepatobiliary Surgery and Nutrition-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleHormonal control of the metabolic machinery of hepatocellular carcinoma-
dc.typeArticle-
dc.identifier.emailWong, CCL: carmencl@pathology.hku.hk-
dc.identifier.emailWong, CM: jcmwong@hku.hk-
dc.identifier.emailNg, IOL: iolng@hku.hk-
dc.identifier.authorityWong, CCL=rp01602-
dc.identifier.authorityWong, CM=rp00231-
dc.identifier.authorityNg, IOL=rp00335-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.21037/hbsn.2016.03.07-
dc.identifier.hkuros264752-
dc.identifier.volume5-
dc.identifier.issue3-
dc.identifier.spage195-
dc.identifier.epage197-
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats